Mirae Asset Global Investments Co., Ltd. Vera Therapeutics, Inc. Transaction History
Mirae Asset Global Investments Co., Ltd.
- $28 Billion
- Q2 2025
A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Vera Therapeutics, Inc. stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 2,464 shares of VERA stock, worth $52,088. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,464
Previous 2,133
15.52%
Holding current value
$52,088
Previous $51,000
13.73%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding VERA
# of Institutions
199Shares Held
64.6MCall Options Held
1.58MPut Options Held
365K-
Avoro Capital Advisors LLC New York, NY6.3MShares$133 Million2.71% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD4.48MShares$94.7 Million0.01% of portfolio
-
Kynam Capital Management, LP Princeton, NJ3.43MShares$72.4 Million9.64% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY3.35MShares$70.8 Million1.81% of portfolio
-
Black Rock Inc. New York, NY3.34MShares$70.6 Million0.0% of portfolio
About Vera Therapeutics, Inc.
- Ticker VERA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 27,042,300
- Market Cap $572M
- Description
- Vera Therapeutics, Inc., a clinical stage biotechnology company, focuses on developing and commercializing treatments for patients with serious immunological diseases in the United States. Its lead product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection that is in Phase IIb clinical trial for patients with ...